In a quiet corner of Rockefeller University, a liquid chromatography machine hums inside Ekaterina V. Vinogradova’s lab, parsing proteins that hold secrets of how our organs whisper to one another. For years, scientists have known that fat talks to the liver, immune cells signal distress, and thousands of proteins ferry messages through the bloodstream—but catching the right speaker in the act has been nearly impossible. Now, a team of researchers has cracked the code. By refining a technique called proximity labeling and deploying it in genetically engineered mice, they’ve built a powerful new platform that traces proteins back to their source cells, revealing the most detailed map yet of inter-organ communication. The breakthrough, published in Cell Reports, doesn’t just spotlight a single molecule—it offers a universal tool to eavesdrop on the body’s hidden conversations.
The challenge has always been one-sided: scientists could detect proteins in the blood but couldn’t reliably trace them to their cellular origins. RNA levels, once used as a proxy, often mislead. Lab-grown cells don’t behave like those in living bodies. Even existing tagging methods missed rare but critical signals. "A major limitation in the field has been how to discover these proteins in vivo," says Paul Cohen, head of the Weslie R. and William H. Janeway Laboratory of Molecular Metabolism. The turning point came when Ken H. Loh, then a postdoc in Jeffrey M. Friedman’s lab, shared a mouse model that tags proteins as they pass through the endoplasmic reticulum—the cellular factory where proteins are folded and prepped for export. When Cohen, Vinogradova, and Loh hit the same technical walls—low signal recovery, noise in mass spectrometry data—they joined forces.
Vinogradova’s team optimized the proteomics workflows, boosting sensitivity and precision, while Cohen and Loh contributed physiological models of fasting, inflammation, and obesity. Together, they mapped how fat and liver cells exchange signals under different conditions, identifying protein networks that shift during metabolic stress. Most strikingly, when they cross-referenced their findings with data from the UK Biobank, they linked 65 of these proteins to human diseases, including type 2 diabetes and cardiovascular conditions. This isn’t just about understanding obesity—it’s about uncovering new biomarkers and therapeutic targets.
"The platform is very broadly applicable," says Vinogradova. "It can be applied to different tissues and different genetic drivers—biologists in any field can use it to study cell-to-cell communication." The implications ripple far beyond metabolism. Imagine tracing inflammatory signals in autoimmune disease, or tracking neuroendocrine messages in the brain. This tool doesn’t just answer old questions—it opens a new way of listening to the body. And somewhere in that quiet lab, a machine keeps listening, one protein at a time.